Go to deals
Healthcare

Synairgen has successfully raised US$114 million to support phase III trial of COVID candidate

Synairgen plc has completed its oversubscribed equity fundraising to raise US$114 million to fund a phase III trial for 900 patients for the effects of its SNG001 drug on patients with COVID-19. In addition, the raise will be used to scale up manufacturing and device activities.

Synairgen engages in the provision of respiratory drug discovery and development. It focuses on severe asthma, chronic obstructive pulmonary disease and severe viral infections, as well as COVID-19. The company was founded by Donna E. Davies, Ratko Djukanovic, and Stephen T. Holgate in June 2003 and is headquartered in Southampton.

Oaklins Cavendish’s sister firm finnCap, based in the UK, acted as advisor to Synairgen plc in this transaction.

“It was particularly pleasing to see the level of support received for this financing, reinforcing confidence in SNG001, our wholly-owned drug and potential breakthrough treatment for COVID-19 patients. Oaklins’ team has always been supportive and built a good register of institutions in March which was broadened further in this funding. It was a very successful fundraising and the level of demand was such that we were comfortably able to increase the size of the funding. Having demonstrated the great promise of SNG001 in hospitalized COVID-19 patients earlier this year, we now have the resources to be able to rapidly progress this potential breakthrough treatment in such a critical area of unmet need.”

Richard Marsden

CEO, Synairgen plc

Talk to the deal team

 Geoff  Nash

Geoff Nash

Director
London, United Kingdom
Oaklins Cavendish

Related deals

Aenza S.A.A. has completed a follow-on
Private Equity | Construction & Engineering Services | Energy | Real Estate

Aenza S.A.A. has completed a follow-on

Aenza S.A.A. has completed af follow-on to prepay part of a recently renegotiated bridge loan.

Learn more
move UP has been acquired by Acture B.V.
Private Equity | Business Support Services | Healthcare

move UP has been acquired by Acture B.V.

move UP Gesellschaft für Gesundheitsmanagement mbH, an innovative provider of holistic corporate health management solutions, has been acquired by Acture B.V., a leader in welfare management. This acquisition represents a major step in Acture’s plans to expand into the German corporate health management sector.

Learn more
Pampa Camarones has completed an IPO
Other Industries

Pampa Camarones has completed an IPO

Pampa Camarones SpA has successfully raised US$5 million through its stock market debut on ScaleX (Santiago Venture Exchange). These funds will be used to extend the mine life and incorporate the high-grade polymetallic project, Ciclón Exploradora.

Learn more